Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Disulfiram × Breast × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 9 Tamoxifen 9 Docetaxel 9 Capecitabine 9 Exercise 7 pyrotinib 6 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Control Groups 6 Carboplatin 6 Vinorelbine 5 Indocyanine Green 5 pertuzumab 4 exemestane 4 Injections 4 Doxorubicin 4 Anastrozole 4 dalpiciclib 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Fulvestrant 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3 Bevacizumab 3 ferumoxides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04265274 2023-10-06

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

National Cancer Institute, Slovakia

Phase 2 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡